Allogene Therapeutics (NASDAQ:ALLO) Price Target Cut to $9.0

Allogene Therapeutics (NASDAQ:ALLO) Price Target Cut to $9.00 by Analysts at HC Wainwright

Allogene Therapeutics (NASDAQ:ALLO) Price Target Cut to $9.00 by Analysts at HC Wainwright

dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Canada , Stifel Nicolaus , Royal Bank , Ieq Capital , Nasdaq , Td Asset Management Inc , Allogene Therapeutics Inc , Mirae Asset Global Investments Co , Principal Financial Group Inc , Victory Capital Management Inc , Jpmorgan Chase Co , Allogene Therapeutics , Free Report , Moderate Buy , Get Free Report , Asset Global Investments , Management Inc , Financial Group , Victory Capital Management , Allogene Therapeutics Daily ,